Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-10-26

FDA Approved: LIOTHYRONINE SODIUM — Original Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved Teva Pharmaceuticals USA, Inc.'s liothyronine sodium as a generic product (ANDA 211510).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Liothyronine Sodium (Liothyronine Sodium)

Snippet

ORIG AP for LIOTHYRONINE SODIUM (LIOTHYRONINE SODIUM)